New ultrasound technique could spot hidden liver cancers

NCT ID NCT06345508

Recruiting now Diagnosis Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a new type of ultrasound, called quantitative ultrasound (QUS), can find liver cancers that standard ultrasound often misses. About 328 adults at risk for liver cancer will receive both QUS and standard ultrasound, and results will be compared to MRI or biopsy. If QUS works better, it could help catch liver cancer earlier, when it is more treatable.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Quantitative Ultrasound (QUS)
What this could lead to: If successful, this could make liver cancer detection more accurate and accessible, catching tumors early when they are curable.
What could go wrong: This is a diagnostic study, not a treatment. The new technique may not prove significantly better than standard ultrasound, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

disease hepatocellular carcinoma liver cancer Liver Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEPATOCELLULAR CARCINOMA LIVER CANCER

Contacts and locations

Locations

Centre Hospitalier de l'Université de Montréal (CHUM)
RECRUITING

Montreal, Quebec, H2X 0A9, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.